|
1
|
Li C, Zhang P, Cheng X and Chen J:
High-volume hemofiltration reduces the expression of myocardial
tumor necrosis factor-alpha in septic shock pigs. Artif Organs.
37:196–202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boussekey N, Chiche A, Faure K, Devos P,
Guery B, D'Escrivan T, Georges H and Leroy O: A pilot randomized
study comparing high and low volume hemofiltration on vasopressor
use in septic shock. Intensive Care Med. 34:1646–1653. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cornejo R, Downey P, Castro R, Romero C,
Regueira T, Vega J, Castillo L, Andresen M, Dougnac A, Bugedo G and
Hernandez G: High-volume hemofiltration as salvage therapy in
severe hyperdynamic septic shock. Intensive Care Med. 32:713–722.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cole L, Bellomo R, Journois D, Davenport
P, Baldwin I and Tipping P: High-volume haemofiltration in human
septic shock. Intensive Care Med. 27:978–986. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oberholzer A, Oberholzer C and Moldawer
LL: Sepsis syndromes: Understanding the role of innate and acquired
immunity. Shock. 16:83–96. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moss RB, Moll T, El-Kalay M, Kohne C, Soo
HW, Encinas J and Carlo DJ: Th1/Th2 cells in inflammatory disease
states: Therapeutic implications. Expert Opin Biol Ther.
4:1887–1896. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abbas AK, Murphy KM and Sher A: Functional
diversity of helper T lymphocytes. Nature. 383:787–793. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harty JT, Tvinnereim AR and White DW: CD8+
T cell effector mechanisms in resistance to infection. Annu Rev
Immunol. 18:275–308. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Walter U and Santamaria P: CD8+
T cells in autoimmunity. Curr Opin Immunol. 17:624–631. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Holmes JH IV, Connolly NC, Paull DL, Hill
ME, Guyton SW, Ziegler SF and Hall RA: Magnitude of the
inflammatory response to cardiopulmonary bypass and its relation to
adverse clinical outcomes. Infamm Res. 51:579–586. 2002. View Article : Google Scholar
|
|
12
|
Hotchkiss RS and Karl IE: The
pathophysiology and treatment of sepsis. N Engl J Med 2003.
348:138–150. 2003.
|
|
13
|
Bone RC: Immunologic dissonance: a
continuing evolution in our understanding of the systemic
infammatory response syndrome (SIRS) and the multiple organ
dysfunction syndrome (MODS). Ann Intern Med. 125:680–687. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levy MM, Fink MP, Marshall JC, Abraham E,
Angus D, Cook D, Cohen J, Opal SM, Vincent JL and Ramsay G:
SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International
Sepsis Definitions Conference. Crit Care Med. 31:1250–1256. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dellinger RP, Levy MM, Rhodes A, Annane D,
Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke
R, et al: Surviving Sepsis Campaign Guidelines Committee including
the Pediatric Subgroup: Surviving sepsis campaign: international
guidelines for management of severe sepsis and septic shock: 2012.
Crit Care Med. 41:580–637. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martin GS, Mannino DM, Eaton S and Moss M:
The epidemiology of sepsis in the United States from 1979 through
2000. N Engl J Med. 348:1546–1554. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ronco C, Bellomo R, Homel P, Brendolan A,
Dan M, Piccinni P and La Greca G: Effects of different doses in
continuous veno-venous haemofiltration on outcomes of acute renal
failure: A prospective randomised trial. Lancet. 356:26–30. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Honore PM, Jamez J, Wauthier M, Lee PA,
Dugernier T, Pirenne B, Hanique G and Matson JR: Prospective
evaluation of short-term, high-volume isovolemic hemofiltration on
the hemodynamic course and outcome in patients with intractable
circulatory failure resulting from septic shock. Crit Care Med.
28:3581–3587. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brendolan A, D'Intini V, Ricci Z, Bonello
M, Ratanarat R, Salvatori G, Bordoni V, De Cal M, Andrikos E and
Ronco C: Pulse high volume hemofiltration. Int J Artif Organs.
27:398–403. 2004.PubMed/NCBI
|
|
20
|
Chu LP, Zhou JJ, Yu YF, Huang Y and Dong
WX: Clinical effects of pulse high-volume hemofiltration on severe
acute pancreatitis complicated with multiple organ dysfunction
syndrome. Ther Apher Dial. 17:78–83. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng Z, Pai P, Han-Min W, Jun Z, Hong-Bao
L, Rong L and Chen H: Evaluation of the effects of pulse
high-volume hemofiltration in patients with severe sepsis: A
preliminary study. Int J Artif Organs. 33:505–511. 2010.PubMed/NCBI
|
|
22
|
Ratanarat R, Brendolan A, Ricci Z,
Salvatori G, Nalesso F, de Cal M, Cazzavillan S, Petras D, Bonello
M, Bordoni V, Cruz D, Techawathanawanna N and Ronco C: Pulse
high-volume hemofiltration in critically ill patients: A new
approach for patients with septic shock. Semin Dial. 19:69–74.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ratanarat R, Brendolan A, Piccinni P, Dan
M, Salvatori G, Ricci Z and Ronco C: Pulse high-volume
haemofiltration for treatment of severe sepsis: Effects on
hemodynamics and survival. Crit Care. 9:R294–R302. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hotchkiss RS, Osmon SB, Chang KC, Wagner
TH, Coopersmith CM and Karl IE: Accelerated lymphocyte death in
sepsis occurs by both the death receptor and mitochondrial
pathways. J Immunol. 174:5110–5118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X and Ye J and Ye J: Analysis of
peripheral blood lymphocyte subsets and prognosis in patients with
septic shock. Microbiol Immunol. 55:736–742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Walley KR, Lukacs NW, Standiford TJ,
Strieter RM and Kunkel SL: Balance of inflammatory cytokines
related to severity and mortality of murine sepsis. Infect Immun.
64:4733–4738. 1996.PubMed/NCBI
|
|
27
|
van der Poll T and Opal SM: Host-pathogen
interactions in sepsis. Lancet Infect Dis. 8:32–43. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calvano SE, Xiao W, Richards DR, Felciano
RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK,
Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG
and Lowry SF: A network-based analysis of systemic inflammation in
humans. Nature. 437:1032–1037. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang RB, Mark MR, Gray A, Huang A, Xie MH,
Zhang M, Goddard A, Wood WI, Gurney AL and Godowski PJ: Toll-like
receptor-2 mediates lipopolysaccharide-induced cellular signalling.
Nature. 395:284–288. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeytun A, van Velkinburgh JC, Pardington
PE, Cary RR and Gupta G: Pathogen-specific innate immune response.
Adv Exp Med Biol. 598:342–357. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang FX, Kirschning CJ, Mancinelli R, Xu
XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M and Arditi M:
Bacterial lipopolysaccharide activates nuclear factor-kappaB
through interleukin-1 signaling mediators in cultured human dermal
endothelial cells and mononuclear phagocytes. J Biol Chem.
274:7611–7614. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lorne E, Dupont H and Abraham E: Toll-like
receptors 2 and 4: Initiators of non-septic inflammation in
critical care medicine? Intensive Care Med. 36:1826–1835. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: Update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Beutler B, Jiang Z, Georgel P, Crozat K,
Croker B, Rutschmann S, Du X and Hoebe K: Genetic analysis of host
resistance: Toll-like receptor signaling and immunity at large.
Annu Rev Immunol. 24:353–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
